Pediatric Speech Therapy Session Frequency and Speech Outcomes
1 other identifier
interventional
39
1 country
1
Brief Summary
Examination of frequency of therapy and effect on clinical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedFirst Submitted
Initial submission to the registry
April 20, 2023
CompletedFirst Posted
Study publicly available on registry
June 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2023
CompletedMay 4, 2026
April 1, 2026
10 months
April 20, 2023
April 28, 2026
Conditions
Outcome Measures
Primary Outcomes (4)
Change in Articulation and intelligibility
Scores on the following standardized measures: Goldman Fristoe Test of Articulation- Third Edition (GFTA-3) ; Average Standard Score range is from 86-114; an increase in standard score indicates improvement in intelligibility.
Baseline, immediately after treatment (up to 4 months)
Change in Receptive vocabulary skills
Scores on the following standardized measure: Receptive One Word Picture Vocabulary Test- Fourth Edition (ROVPVT-4); Average Standard Score range is from 85-115; an increase in standard score indicates improvement in understanding vocabulary.
Baseline, immediately after treatment (up to 4 months)
Change in Expressive vocabulary skills
Scores on the following standardized measure: Expressive One Word Picture Vocabulary Test- Fourth Edition (EOWPVT-4); Average Standard Score range is from 85-115; an increase in standard score indicates improvement in understanding or labeling vocabulary.
Baseline, immediately after treatment (up to 4 months)
Change in Receptive and expressive early language skills
Scores on the following standardized measures: Receptive-Expressive Emergent Language Scale- Fourth Edition (REEL-4); Average Standard Score range is from 90-109; an increase in standard score indicates improvement in language ability score.
Baseline, immediately after treatment (up to 4 months)
Secondary Outcomes (1)
Home Exercise Plan (HEP) provision
up to 4 months
Study Arms (2)
Every-other-week therapy with home programming
ACTIVE COMPARATORReceipt of standard speech therapy care (every-other-week) for 8.0 sessions
Weekly therapy with home programming
EXPERIMENTALReceipt of speech therapy care (every week) for 8.0 sessions
Interventions
Delivery of speech therapy services
Eligibility Criteria
You may qualify if:
- Medical order for speech therapy
- Patients eligible for speech therapy at Connecticut Children's (qualify for receptive, expressive language and/or articulation therapy)
- Diagnosis of communication disorder.ICD-10 codes will be utilized pertaining to expressive, receptive language and articulation disorders (ICD-10 code specific to patient: F80.0, F80.1, F80.2, F80.4, F80.9, R47.89, R41.841)
- Patient recommended for individual (i.e. not group) treatment
- months to 16 years of age
- Completed 1 plan of care (POC) with a duration of 8 sessions
- Attended at least 80% of scheduled visits during their plan of care period (still completing 8 sessions of therapy, may have extended time to completion).
- Services for a full 8-session plan of care.
You may not qualify if:
- \- Seeking speech therapy care for treatment of disorders related to diagnosis of voice, feeding, fluency, and/or cognition
- Patient unable to complete standardized tests (EOWPVT-4, ROWPVT-4, GFTA-3, REEL-4)
- Patients in group speech therapy
- Patients younger than 18 months or older than 16 years of age
- Not willing to complete a full POC (8 sessions)
- Unable/unwilling to attend 80% of scheduled visits
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Connecticut Children's Medical Center
Hartford, Connecticut, 06106, United States
Related Publications (1)
Van Epps VM, Daur-Schierholz M, Dortenzio M, Mendillo E, Urzua J, Brimacombe M, Hinderer KA. How changes to frequency of treatment and mode of treatment improved paediatric speech-language pathology services: A pragmatic clinical trial. Int J Speech Lang Pathol. 2026 Mar 8:1-12. doi: 10.1080/17549507.2026.2630835. Online ahead of print.
PMID: 41795638RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Virginia Van Epps, M.Ed.
Connecticut Children's Medical Center
- STUDY DIRECTOR
Mary Dortenzio, MS
Connecticut Children's Medical Center
- STUDY DIRECTOR
Jodi Urzua, MS
Connecticut Children's Medical Center
- STUDY DIRECTOR
Emma Mendillo, MA
Connecticut Children's Medical Center
- STUDY DIRECTOR
Morgan Daur-Schierholz, MS
Connecticut Children's Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 20, 2023
First Posted
June 12, 2023
Study Start
January 1, 2023
Primary Completion
October 30, 2023
Study Completion
October 30, 2023
Last Updated
May 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share